Microcystin-LR structure
|
Common Name | Microcystin-LR | ||
|---|---|---|---|---|
| CAS Number | 101043-37-2 | Molecular Weight | 995.172 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C49H74N10O12 | Melting Point | N/A | |
| MSDS | USA | Flash Point | 11 °C | |
| Symbol |
GHS02, GHS06, GHS08 |
Signal Word | Danger | |
Use of Microcystin-LRMicrocystin-LR is a potent inhibitor of type 1 and type 2A protein phosphatases (PP1 and PP2A), with IC50s of 1.7 nM and 0.04 nM, respectively. Sequence: Ala-D-Ala-Leu-D-{Bas}-Arg-{Oaa}-D-{Ggu}. |
| Name | microcystin-LR |
|---|---|
| Synonym | More Synonyms |
| Description | Microcystin-LR is a potent inhibitor of type 1 and type 2A protein phosphatases (PP1 and PP2A), with IC50s of 1.7 nM and 0.04 nM, respectively. Sequence: Ala-D-Ala-Leu-D-{Bas}-Arg-{Oaa}-D-{Ggu}. |
|---|---|
| Related Catalog | |
| Target |
IC50: 1.7 nM (PP1), 0.04 nM (PP2A)[1]. |
| In Vitro | Microcystins are toxic molecules produced by cyanobacterial blooms due to water eutrophication[2]. Microcystin-LR proves to be a potent inhibitor of type 1 (IC50=1.7 nM) and type 2A (IC50= 0.04 nM) protein phosphatases. Microcystin-LR inhibits the activity of both type 1 and type 2A phosphatases >10-fold more potently than okadaic acid under the same conditions. Type 2A protein phosphatases in dilute mammalian cell extracts are found to be completely inhibited by 0.5 nM microcystin-LR while type 1 protein phosphatases are only slightly affected at this concentration[1]. |
| References |
[2]. Lone Y, et al. Microcystin-LR Induced Immunotoxicity in Mammals. J Toxicol. 2016:8048125. |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Molecular Formula | C49H74N10O12 |
| Molecular Weight | 995.172 |
| Flash Point | 11 °C |
| Exact Mass | 994.548767 |
| PSA | 340.64000 |
| LogP | -1.54 |
| Appearance of Characters | solid film |
| Index of Refraction | 1.598 |
| InChIKey | ZYZCGGRZINLQBL-GWRQVWKTSA-N |
| SMILES | C=C1C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(C(=O)O)C(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(C=CC(C)=CC(C)C(Cc2ccccc2)OC)C(C)C(=O)NC(C(=O)O)CCC(=O)N1C |
| Water Solubility | ethanol: 1 mg/mL |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS02, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H301-H311-H331-H370 |
| Precautionary Statements | P210-P260-P280-P301 + P310-P311 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US) |
| Hazard Codes | T+ |
| Risk Phrases | 26/27/28-36/37/38-43 |
| Safety Phrases | S26;S45;S36/S37/S39 |
| RIDADR | UN 2811 6.1/PG 1 |
| WGK Germany | 3 |
| RTECS | GT2810000 |
| Hazard Class | 6.1 |
|
~%
Microcystin-LR CAS#:101043-37-2 |
| Literature: Chemical Research in Toxicology, , vol. 11, # 3 p. 159 - 163 |
|
Growth inhibition and microcystin degradation effects of Acinetobacter guillouiae A2 on Microcystis aeruginosa.
Res. Microbiol. 166(2) , 93-101, (2015) Strain A2 with algicidal activity against Microcystis aeruginosa was isolated and identified with the genus Acinetobacter on the basis of phenotypic tests and 16S rRNA gene analysis. It was identified... |
|
|
Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets.
J. Thromb. Haemost. 12(5) , 748-60, (2014) Rapamycin, an inhibitor of mammalian target of rapamycin complex-1 (mTORC1), reduces platelet spreading, thrombus stability, and clot retraction. Despite an important role of mTORC1 in platelet functi... |
|
|
Sensitive detection of microcystin-LR by using a label-free electrochemical immunosensor based on Au nanoparticles/silicon template/methylene blue nanocomposite.
J. Nanosci. Nanotechnol. 13(12) , 8245-52, (2013) A label-free electrochemical immunosensor, based on a gold nanoparticles (Au NPs)/silicon template/methylene blue (MB)/chitosan (CHIT) nanocomposite-modified electrode, was fabricated for the ultrasen... |
| akerstox |
| TOXIN,BLUE-GREENALGA |
| EINECS 200-659-6 |
| Microcystin-LR |
| microcystin-lr solution |
| 1,4,7,10,14,17,21-Heptaazacyclopentacosa-3,6,9,13,16,20-hexaene-11,22-dicarboxylic acid, 15-[3-[(aminoiminomethyl)amino]propyl]-3,6,9,13,16,20-hexahydroxy-18-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenyl-1,3-heptadien-1-yl]-1,5,12,19-tetramethyl-2-methylene-8-(2-methylpropyl)-25-oxo-, (3E,5R,6E,8S,9E,11R,12S,13E,15S,16E,18S,19S,20E,22R)- |
| toxin-lr |
| microcystin LR |
| MFCD00131607 |
| 1,4,7,10,14,17,21-Heptaazacyclopentacosane-11,22-dicarboxylic acid, 15-[3-[(aminoiminomethyl)amino]propyl]-18-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenyl-1,3-heptadien-1-yl]-1,5,12,19-tetramethyl-2-methylene-8-(2-methylpropyl)-3,6,9,13,16,20,25-heptaoxo-, (5R,8S,11R,12S,15S,18S,19S,22R)- |
| 5-L-Arginine-cyanoginosin |
| (3E,5R,6E,8S,9E,11R,12S,13E,15S,16E,18S,19S,20E,22R)-15-(3-Carbamimidamidopropyl)-3,6,9,13,16,20-hexahydroxy-8-isobutyl-18-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenyl-1,3-heptadien-1-yl]-1,5,12,19-tetramethyl-2-methylene-25-oxo-1,4,7,10,14,17,21-heptaazacyclopentacosa-3,6,9,13,16,20-hexaene-11,22-dicarboxylic acid |
| 5-L-Arginine-microcystin LA |
| microcystin-a |
| MCYST-LR |
| (5R,8S,11R,12S,15S,18S,19S,22R)-15-(3-Carbamimidamidopropyl)-8-isobutyl-18-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenyl-1,3-heptadien-1-yl]-1,5,12,19-tetramethyl-2-methylene-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptaazacyclopentacosane-11,22-dicarboxylic acid |
| CYANOGINOSIN-LR |